These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 9830682)
1. Exchange of bound estrogens and antiestrogens in MCF-7 cells: evidence for ligand-induced stable configurations of the estrogen receptor. El khissiin A; Leclercq G Steroids; 1998 Nov; 63(11):565-74. PubMed ID: 9830682 [TBL] [Abstract][Full Text] [Related]
2. Estrogenic and antiestrogenic regulation of the half-life of covalently labeled estrogen receptor in MCF-7 breast cancer cells. Borrás M; Laios I; el Khissiin A; Seo HS; Lempereur F; Legros N; Leclercq G J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):203-13. PubMed ID: 8645630 [TBL] [Abstract][Full Text] [Related]
3. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens. Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652 [TBL] [Abstract][Full Text] [Related]
4. Estrogen and antiestrogen interaction with estrogen receptor of MCF-7 cells--relationship between processing and estrogenicity. Gyling M; Leclercq G J Steroid Biochem; 1988 Jan; 29(1):1-8. PubMed ID: 3347042 [TBL] [Abstract][Full Text] [Related]
5. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells. Marsaud V; Gougelet A; Maillard S; Renoir JM Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746 [TBL] [Abstract][Full Text] [Related]
6. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists. Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965 [TBL] [Abstract][Full Text] [Related]
7. The pure antiestrogen ICI 182,780 binds to a high-affinity site distinct from the estrogen receptor. Parisot JP; Hu XF; Sutherland RL; Wakeling A; Zalcberg JR; DeLuise M Int J Cancer; 1995 Aug; 62(4):480-4. PubMed ID: 7635575 [TBL] [Abstract][Full Text] [Related]
8. Estrogenic and anti-estrogenic regulation of estrogen receptor in MCF-7 breast-cancer cells: comparison of immunocytochemical data with biochemical measurements. Seo HS; Larsimont D; Querton G; El Khissiin A; Laios I; Legros N; Leclercq G Int J Cancer; 1998 Dec; 78(6):760-5. PubMed ID: 9833770 [TBL] [Abstract][Full Text] [Related]
9. Comparison of tamoxifen ligands on estrogen receptor interaction with estrogen response elements. Klinge CM; Studinski-Jones AL; Kulakosky PC; Bambara RA; Hilf R Mol Cell Endocrinol; 1998 Aug; 143(1-2):79-90. PubMed ID: 9806352 [TBL] [Abstract][Full Text] [Related]
10. Protein synthesis is not implicated in the ligand-dependent activation of the estrogen receptor in MCF-7 cells. El Khissiin A; Cleeren A; Borràs M; Leclercq G J Steroid Biochem Mol Biol; 1997 Jul; 62(4):269-76. PubMed ID: 9408080 [TBL] [Abstract][Full Text] [Related]
11. Differences between estrogen- and antiestrogen-estrogen receptor complexes from human breast tumors identified with an antibody raised against the estrogen receptor. Tate AC; Greene GL; DeSombre ER; Jensen EV; Jordan VC Cancer Res; 1984 Mar; 44(3):1012-8. PubMed ID: 6692388 [TBL] [Abstract][Full Text] [Related]
12. Evidence of an estrogen receptor form devoid of estrogen binding ability in MCF-7 cells. El Khissiin A; Journé F; Laïos I; Seo HS; Leclercq G Steroids; 2000 Dec; 65(12):903-13. PubMed ID: 11077089 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen. Attardi B; Happe HK Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150 [TBL] [Abstract][Full Text] [Related]
14. Decrease of estrogen receptor expression and associated ERE-dependent transcription in MCF-7 breast cancer cells after oligomycin treatment. Seo HS; Journé F; Larsimont D; Sotiriou C; Leclercq G Steroids; 2003 Mar; 68(3):257-69. PubMed ID: 12628689 [TBL] [Abstract][Full Text] [Related]
16. Interaction and dissociation by ligands of estrogen receptor and Hsp90: the antiestrogen RU 58668 induces a protein synthesis-dependent clustering of the receptor in the cytoplasm. Devin-Leclerc J; Meng X; Delahaye F; Leclerc P; Baulieu EE; Catelli MG Mol Endocrinol; 1998 Jun; 12(6):842-54. PubMed ID: 9626660 [TBL] [Abstract][Full Text] [Related]
17. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Pink JJ; Jordan VC Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307 [TBL] [Abstract][Full Text] [Related]
18. Regulation of estrogen and progestin receptor concentrations in an experimental rat prostatic carcinoma by estrogen, antiestrogen, and progesterone. Mobbs BG; Johnson IE; DeSombre ER; Toth J; Hughes A Cancer Res; 1987 May; 47(10):2645-51. PubMed ID: 3552202 [TBL] [Abstract][Full Text] [Related]
19. Interaction of the antiestrogen [3H]H1285 with the two forms of the molybdate-stabilized calf uterine estrogen receptor. Keene JL; Ruh MF; Ruh TS J Steroid Biochem; 1984 Dec; 21(6):625-31. PubMed ID: 6527530 [TBL] [Abstract][Full Text] [Related]
20. Antiestrogen-liganded estrogen receptor interaction with estrogen responsive element DNA in vitro. Klinge CM; Bambara RA; Hilf R J Steroid Biochem Mol Biol; 1992 Oct; 43(4):249-62. PubMed ID: 1390277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]